[Randomized study of the antiemetic efficacy of alizapride versus alizapride + dexamethasone].

Giornale italiano di oncologia Pub Date : 1990-10-01
C Epifani, G Scognamiglio, C Prete, F Alberio, G Gini, M Valli
{"title":"[Randomized study of the antiemetic efficacy of alizapride versus alizapride + dexamethasone].","authors":"C Epifani,&nbsp;G Scognamiglio,&nbsp;C Prete,&nbsp;F Alberio,&nbsp;G Gini,&nbsp;M Valli","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>We made a study on patients suffering from neoplasias treated with cisplatinum to compare antiemetic efficacy of alizapride or associated to dexamethasone. We divided patients in two groups. We somministred alizapride alone to the first group and alizapride plus dexamethasone to the second one. We evaluated presence or absence of emesis, its intensity and eventual tossic effects due to the drugs through an autocompilative questionnaire given to the patients. Our results didn't show important statistical differences between the two groups, though association with dexamethasone gets better emesis control. Alizapride anyway, didn't present important collateral effects, particularly extrapyramidal ones.</p>","PeriodicalId":77541,"journal":{"name":"Giornale italiano di oncologia","volume":"10 4","pages":"115-9"},"PeriodicalIF":0.0000,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale italiano di oncologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We made a study on patients suffering from neoplasias treated with cisplatinum to compare antiemetic efficacy of alizapride or associated to dexamethasone. We divided patients in two groups. We somministred alizapride alone to the first group and alizapride plus dexamethasone to the second one. We evaluated presence or absence of emesis, its intensity and eventual tossic effects due to the drugs through an autocompilative questionnaire given to the patients. Our results didn't show important statistical differences between the two groups, though association with dexamethasone gets better emesis control. Alizapride anyway, didn't present important collateral effects, particularly extrapyramidal ones.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[阿利沙匹利与阿利沙匹利+地塞米松止吐疗效的随机研究]。
我们对使用顺铂治疗的肿瘤患者进行研究,比较阿利沙利或与地塞米松联合使用的止吐效果。我们把病人分成两组。我们给第一组服用阿利沙必利给第二组服用阿利沙必利加地塞米松。我们通过给患者的自编问卷来评估呕吐的存在与否、呕吐的强度和最终的呕吐效应。我们的结果在两组之间没有明显的统计学差异,尽管联合使用地塞米松可以更好地控制呕吐。不管怎样,阿利沙必利并没有产生重要的副作用,尤其是锥体外系的副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Clodronate and radiotherapy for the treatment of osteolysis caused by metastasis of breast carcinoma and non-small cell lung carcinoma. A retrospective study]. [Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms]. [Randomized study of the antiemetic efficacy of alizapride versus alizapride + dexamethasone]. [The use of ranitidine in antineoplastic polychemotherapy]. [Multiple myeloma: epidemiologic and clinical considerations].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1